Login to Your Account



Biotech Foundations

CureDuchenne Ventures Launches with $5M Commitment to Lexicon

By Catherine Shaffer
Staff Writer

Friday, September 27, 2013
People with Duchenne muscular dystrophy (DMD) have gained a powerful new ally in CureDuchenne Ventures, a nonprofit organization dedicated to funding drug discovery and development for the rare disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription